MA, V., ES, K., CA, T., J, L., C, S., SJ, P., . . . A, L. (2026). Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy. JCO oncology practice, 22(2), 306. https://doi.org/10.1200/OP-25-00027
Chicago Style (17th ed.) CitationMA, Velez, et al. "Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy." JCO Oncology Practice 22, no. 2 (2026): 306. https://doi.org/10.1200/OP-25-00027.
MLA (9th ed.) CitationMA, Velez, et al. "Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy." JCO Oncology Practice, vol. 22, no. 2, 2026, p. 306, https://doi.org/10.1200/OP-25-00027.
Warning: These citations may not always be 100% accurate.